We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A reliable cell-based assay for testing unclassified TSC2 gene variants.
- Authors
Coevoets, Ricardo; Arican, Sermin; Hoogeveen-Westerveld, Marianne; Simons, Erik; van den Ouweland, Ans; Halley, Dicky; Nellist, Mark
- Abstract
Tuberous sclerosis complex (TSC) is characterised by seizures, mental retardation and the development of hamartomas in a variety of organs and tissues. The disease is caused by mutations in either the TSC1 gene or the TSC2 gene. The TSC1 and TSC2 gene products, TSC1 and TSC2, form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR). We have developed a straightforward, semiautomated in-cell western (ICW) assay to investigate the effects of amino acid changes on the TSC1-TSC2-dependent inhibition of mTOR activity. Using this assay, we have characterised 20 TSC2 variants identified in individuals with TSC or suspected of having the disease. In 12 cases, we concluded that the identified variant was pathogenic. The ICW is a rapid, reproducible assay, which can be applied to the characterisation of the effects of novel TSC2 variants on the activity of the TSC1-TSC2 complex.
- Publication
European journal of human genetics : EJHG, 2009, Vol 17, Issue 3, p301
- ISSN
1476-5438
- Publication type
Journal Article
- DOI
10.1038/ejhg.2008.184